CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 482267-482332 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Leptin levels in subgroups of patients with multiple sclerosis A.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T64312","span":{"begin":0,"end":65},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T64312","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T47","span":{"begin":0,"end":65},"obj":"Sentence"}],"attributes":[{"subj":"T47","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3297","span":{"begin":44,"end":62},"obj":"Disease"},{"id":"T65269","span":{"begin":44,"end":62},"obj":"Disease"}],"attributes":[{"id":"A3297","pred":"mondo_id","subj":"T3297","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A83800","pred":"mondo_id","subj":"T65269","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T3297","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T65269","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93ab","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93c5ec"},{"id":"CORD-19-PD-MONDO","color":"#dfec93"}]}]}}